Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Recs

0
Player Avatar cheaply (< 20) Submitted: 2/8/2011 12:00:47 PM : Outperform Start Price: $3.39 ALTH Score: -47.61

Bottom fishing.

Report this Post Reply

Featured Broker Partners


Advertisement